EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against GW Pharmaceuticals plc – GWPH
March 09 2016 - 7:46PM
Rosen Law Firm, a global investor rights law firm, announces the
filing of a class action lawsuit on behalf of purchasers of GW
Pharmaceuticals plc securities (NASDAQ:GWPH) from December 4, 2014
through January 8, 2016, both dates inclusive (the “Class Period”).
The lawsuit seeks to recover damages for GW Pharmaceuticals
investors under the federal securities laws.
To join the GW Pharmaceuticals class action, go to
the firm’s website at http://rosenlegal.com/cases-821.html or call
Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE
ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY
COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS
MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR
CHOICE.
According to the lawsuit, throughout the Class
Period, Defendants issued materially false and misleading
statements to investors and/or failed to disclose that: (1) GW
Pharmaceuticals lacked effective internal financial controls; (2)
GW Pharmaceuticals lacked effective controls over completeness and
valuation of clinical trial accruals; and (3) as a result,
Defendants’ statements about GW Pharmaceuticals’ business,
operations, and prospects were false and misleading and/or lacked a
reasonable basis at all relevant times. When the true details
entered the market, the lawsuit claims that investors suffered
damages.
A class action lawsuit has already been filed. If
you wish to serve as lead plaintiff, you must move the Court no
later than March 21, 2016. A lead plaintiff is a representative
party acting on behalf of other class members in directing the
litigation. If you wish to join the litigation, go to the firm’s
website at http://rosenlegal.com/cases-821.html or to discuss your
rights or interests regarding this class action, please contact
Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free
at 866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout
the globe, concentrating its practice in securities class actions
and shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Jul 2023 to Jul 2024